Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
Clinical trial NCT03097107 · SUSPENDED
Trial details
- NCT number
- NCT03097107
- Sponsor
- Zydus Therapeutics Inc.
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-06
- Primary completion
- 2023-12-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.